Annual Returns for the Newcastle Haemophilia Centre were produced for 1981. Read more about Annual Returns for the Newcastle Haemophilia Centre were produced for 1981.
Annual Returns for the Newcastle Haemophilia Centre were produced for 1980. Read more about Annual Returns for the Newcastle Haemophilia Centre were produced for 1980.
Haemophilia Centre Directors Hepatitis Working Party Report For Years 1980-81 was published Read more about Haemophilia Centre Directors Hepatitis Working Party Report For Years 1980-81 was published
Minutes of the twelfth meeting of the Haemophilia Centre Directors where they received Dr Craske's report on behalf of the Hepatitis Working Party for 1980-81 with its recommendations that surveillance and further studies should continue. Read more about Minutes of the twelfth meeting of the Haemophilia Centre Directors where they received Dr Craske's report on behalf of the Hepatitis Working Party for 1980-81 with its recommendations that surveillance and further studies should continue.
Supposedly hepatitis-free concentrate was discussed at the twelfth meeting of the Haemophilia Reference Centre Directors. Dr Kernoff stated that this should be used if it were to be introduced into the UK and that the matter should be referred to the Hepatitis Working Party for consideration and recommendation. Read more about Supposedly hepatitis-free concentrate was discussed at the twelfth meeting of the Haemophilia Reference Centre Directors. Dr Kernoff stated that this should be used if it were to be introduced into the UK and that the matter should be referred to the Hepatitis Working Party for consideration and recommendation.
Minutes of the ninth meeting of UK Haemophilia Centre Directors' Hepatitis Working Party where Dr Craske presented preliminary data of results from a 4 year surveillance of Factor VIII and IX associated hepatitis, it was recorded that an application had been made to the MRC with a view to a prospective study of patients with mild defects undergoing treatment requiring concentrate cover. Read more about Minutes of the ninth meeting of UK Haemophilia Centre Directors' Hepatitis Working Party where Dr Craske presented preliminary data of results from a 4 year surveillance of Factor VIII and IX associated hepatitis, it was recorded that an application had been made to the MRC with a view to a prospective study of patients with mild defects undergoing treatment requiring concentrate cover.
The heat-treated concentrates began to be available in May 1984 and from June 1984 the only concentrates being used were heat-treated Factor 8 and 9 both for hospital treatment and home treatment and prophylactically for children. Read more about The heat-treated concentrates began to be available in May 1984 and from June 1984 the only concentrates being used were heat-treated Factor 8 and 9 both for hospital treatment and home treatment and prophylactically for children.
During December 1983, in relation to Dr Winter's decision to shift to using heat-treated concentrates (from Alpha) on a named patient basis. Dr Winter recalled Professor Bloom's reaction in saying that he was mad to switch as there will never be HIV in BPL Factor VIII. Read more about During December 1983, in relation to Dr Winter's decision to shift to using heat-treated concentrates (from Alpha) on a named patient basis. Dr Winter recalled Professor Bloom's reaction in saying that he was mad to switch as there will never be HIV in BPL Factor VIII.
In December 1983, following discussions with Dr Savidge, Dr Winter decided to start using heat-treated concentrates (from Alpha) on a named patient basis. Read more about In December 1983, following discussions with Dr Savidge, Dr Winter decided to start using heat-treated concentrates (from Alpha) on a named patient basis.
Dr Winter held that at the Haemophilia Centre in Margate that around the time of 1983 that due to a lack of funding pharmacists would not have adequate access to NHS concentrate from RTC. Read more about Dr Winter held that at the Haemophilia Centre in Margate that around the time of 1983 that due to a lack of funding pharmacists would not have adequate access to NHS concentrate from RTC.